Who are Sodium picosulphate with magnesium citrate's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-picosulphate-with-magnesium-citrate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Sodium picosulphate with magnesium citrate — Competitive Intelligence Brief

Sodium picosulphate with magnesium citrate (Sodium picosulphate with magnesium citrate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Stimulant laxative with osmotic agent combination. Area: Gastroenterology.

phase 3 Stimulant laxative with osmotic agent combination Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Sodium picosulphate with magnesium citrate (Sodium picosulphate with magnesium citrate) — Korea University Anam Hospital. Sodium picosulphate acts as a stimulant laxative that increases intestinal motility, while magnesium citrate provides osmotic laxative effects to draw water into the bowel.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sodium picosulphate with magnesium citrate TARGET	Sodium picosulphate with magnesium citrate	Korea University Anam Hospital	phase 3	Stimulant laxative with osmotic agent combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Stimulant laxative with osmotic agent combination class)

Korea University Anam Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sodium picosulphate with magnesium citrate — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-picosulphate-with-magnesium-citrate. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab